lifestyle.sourcefed.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Senti Biosciences, Inc.
Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies
April 1, 2026
Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
March 27, 2026
Senti Biosciences to Present Clinical and Translational Data on SENTI-202 at the 11th Annual Innate Killer Conference
March 23, 2026
Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference
March 3, 2026
Senti Biosciences to Present at TD Cowen 46th Annual Health Care Conference
February 24, 2026
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development
February 20, 2026
Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)
February 12, 2026
Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026
February 11, 2026